Surgery and adjuvant chemotherapy with high-dose methotrexate and folinic acid rescue for infiltrating tumors of the bladder
Socquet, Y.
Cancer Treatment Reports 65(Suppl 1): 187-189
1981
ISSN/ISBN: 0361-5960 PMID: 6976831 Document Number: 180655
Thirty-three patients with category T3 or T4 bladder cancer were treated by partial or total cystectomy followed by 6 to 12 courses of high-dose methotrexate (HDMTX) with folinic acid rescue. Survival at 2 years was 90%. Two patients were treated palliatively with HDMTX alone, one of whom is alive and disease free after 35 months.
Document emailed within 1 workday
Related Documents
Pratt, C.B.; Roberts, D.; Shanks, E.C.; Warmath, E.L. 1974: Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors Cancer Research 34(12): 3326-3331Colucci, G.; Maiello, E.; Leo, S.; Giuliani, F.; Pedicini, A.; Pezzella, G.; Valori, V.; Galetta, D.; Contillo, A.; Prete, F. 1994: Biochemical modulation of fluorouracil with high dose methotrexate or folinic acid in advanced colorectal cancer patients. Gruppo Oncologico dell' Italia Meridionale (GOIM) Anticancer Research 14(5b): 2157-2162
Srisomboon, J.; Suprasert, P.; Phongnarisorn, C.; Charoenkwan, K.; Siriaree, S.; Cheewakriangkrai, C.; Tantipalakorn, C.; Kietpeerakool, C. 2005: Treatment results of methotrexate and folinic acid as primary chemotherapy for nonmetastatic gestational trophoblastic neoplasia Journal of the Medical Association of Thailand 88(7): 886-890
Isacoff, W.H.; Morrison, P.F.; Aroesty, J.; Willis, K.L.; Block, J.B.; Lincoln, T.L. 1977: Pharmacokinetics of high-dose methotrexate with citrovorum factor rescue Cancer Treatment Reports 61(9): 1665-1674
Isacoff, W.H.; Eilber, F.; Tabbarah, H.; Klein, P.; Dollinger, M.; Lemkin, S.; Sheehy, P.; Cone, L.; Rosenbloom, B.; Sieger, L.; Block, J.B. 1978: Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue Cancer Treatment Reports 62(9): 1295-1304
Tsurusawa, M.; Sasaki, K.; Matsuoka, H.; Katano, N.; Fujimoto, T. 1985: Studies on high-dose methotrexate with citrovorum factor rescue therapy in children: analysis of bone marrow cell kinetics by flow cytometry Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(9): 1827-1832
Razis, E.D.; Samonis, G.; Cook, P.; Beer, M.; Mittelman, A.; Lake, D.E.; Feldman, E.J.; Puccio, C.; Ahmed, T. 1994: TMJ: a well-tolerated high-dose regimen for the adjuvant chemotherapy of high risk breast cancer Journal of Medicine 25(3-4): 241-250
Maier, U.; Kuber, W. 1983: Drug prevention of recurrence in bladder tumors. Intravesical adriblastin instillation following transurethral resection of non-infiltrating bladder tumors Fortschritte der Medizin 101(12): 535-540
Zander, A.R.; Spitzer, G.; Legha, S.; Dicke, D.A.; Verma, D.S.; Johnston, D.A.; Vellekoop, L.; Beran, M.; Schell, F.; Minnhaar, G.; Blumenschein, G.R.; Bodey, G.P. 1982: High-dose AMSA and bone marrow rescue in patients with solid tumors Cancer Treatment Reports 66(2): 385-386
Schmid, H.P.; Studer, U.E. 1997: Adjuvant chemotherapy after cystectomy for bladder tumors staged as superior or equal to pT3 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(1): 102-104
1988: Postoperative adjuvant chemotherapy of high dose MTX for osteogenic sarcoma Zhonghua Zhong Liu Za Zhi 10(3): 233-235
Ortiz, Z.; Shea, B.; Suarez-Almazor, M.E.; Moher, D.; Wells, G.A.; Tugwell, P. 1998: The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials Journal of Rheumatology 25(1): 36-43
Asaumi, J. 1997: Influence of stage classification, tumor differentiation and mode of invasion against clinical and histopathological effects on low dose sequential methotrexate and 5-fluorouracil administration as neo-adjuvant chemotherapy for oral squamous cell carcinoma In Vivo 11(2): 147-151
Köppler, H.; Pflüger, K.H.; Havemann, K. 1991: High-dose chemotherapy with autologous bone marrow rescue: haematopoietic reconstitution by non-cryopreserved marrow Bone Marrow Transplantation 7(Suppl 2): 143
Colombo, R. 2006: Only an overall 15% net benefit emerges in favour of adjuvant intravesical chemotherapy when compared to transurethral resection alone for the prevention of recurrences of superficial bladder tumors European Urology 50(2): 233-234
Tomita, K. 1986: Experimental studies on high-dose methotrexate with citrovorum factor chemotherapy for 89Sr-induced osteosarcoma murine model Japanese Journal of Antibiotics 39(5): 1219-1227
Gibbons, R.P. 1993: Bladder sparing in infiltrating tumors of the bladder: a reasonably sound option? Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 3(1): 17-18
Escudero Barrilero, A.; Platas, A.; Fernández, A.; Fernández, E.; Rodríguez Luna, J.M.; Ruiz, C.; Maganto, E.; Romero, J. 1989: Infiltrating transitional carcinoma of the bladder. Is the P/T ratio a reliable index to evaluate the effectiveness of preoperative radiotherapy on tumors of the bladder? Archivos Espanoles de Urologia 42(3): 229-235
Tonanont, M.; Inthasorn, P.; Boriboonhirunsarn, D.; Wongthiraporn, W.; Suphanit, I. 2005: Response to initial treatment of low and intermediate risk gestational trophoblastic disease with methotrexate and folinic acid Journal of the Medical Association of Thailand 88(10): 1349-1354
Browman, G.P. 1982: Comparison of thymidine and folinic acid protection from methotrexate toxicity in human lymphoid cell lines Cancer Treatment Reports 66(12): 2051-2059